27:25
creatine
Rather than hand down a simple do/don't-take verdict, Peter Attia and guest Nick lay out a six-question framework for evaluating any exogenous molecule (drug or supplement) and then run creatine—positioned as the model case study—through it in depth, concluding creatine is a low-risk, modest-reward supplement with strong evidence for muscle performance and emerging, more tentative evidence for memory and female-specific hormonal benefits.
Supplements are not regulated by the FDA with the same rigor as pharmaceuticals; the 'generally regarded as safe' category is not an entirely rigorous process.
The video frames the medicine-vs-supplement distinction as less clean than people assume, applying one evaluation framework to both.
The core deliverable is a six-question supplement evaluation framework, walked through explicitly before the creatine case study.
Creatine improves muscle performance by roughly 5-10%, possibly up to 15%, particularly for power, hypertrophy, and high-intensity/anaerobic activity.
Creatine does not augment aerobic/endurance performance; a meta-analysis found no endurance benefit for trained athletes.
Effectiveness plateaus at a 3-5g daily maintenance dose; a historical loading protocol used 20g/day.
Mechanism: phosphocreatine acts as a phosphate donor to regenerate ATP, relevant to roughly 10-second all-out efforts (e.g. a 40-yard dash), not oxidative/aerobic pathways.
No biomarker exists to track creatine tissue saturation, so dosing is protocol-based rather than personally titrated.
Women may derive more benefit per dose than men, largely due to lower baseline creatine stores tied to smaller average muscle mass, while dosed at similar absolute amounts.
Creatine may help across periods of rapid hormonal change (menstrual cycle, pregnancy, perimenopause, menopause), with weak evidence for reduced depression in women; pregnancy safety data is insufficient.
A 2024 meta-analysis of 16 RCTs found a positive effect of creatine on memory; a 2017 review found creatine helps injury prevention and recovery.
Creatine's overall profile is judged low-risk, modest-reward, backed by robust safety data.
Once muscle creatine stores are saturated, excess is metabolized by the liver and cleared by the kidneys.
High-dose creatine elevates serum creatinine, a marker doctors use to assess kidney function, so patients should disclose creatine use before blood tests and consider a 1-2 week washout if kidney function is imperfect.
Creatine monohydrate is presented as the only form with evidence behind it, inexpensive, and the standard to buy with no fillers.
The supplement space is characterized as having far more (10-100x) nefarious quality/marketing behavior than the pharmaceutical space, despite looser regulation optics.
Fish oil is introduced as the next case study, framed by the same deficiency-correction-vs-supramaximal-levels question, but the sneak peek ends before it is worked through.
Six-Question Supplement Evaluation Framework — A six-question framework for evaluating any exogenous molecule (medication or supplement): whether it corrects a deficiency or targets supranormal levels, whether the goal is lifespan or healthspan, and if lifespan whether it targets a specific disease or is broadly geroprotective, if healthspan which apparatus (physical, cognitive, emotional) it serves, whether a biomarker exists to track its therapeutic window, and whether its mechanism of action is understood — capped by a risk-reward assessment of side effects, effect size, safety-data confidence, and supplement quality. Apply: Run any supplement or medication on your list through the six questions in order, ending with the risk-reward check, before deciding whether to keep taking it.
Bucket of Exogenous Molecules Audit — A clinical intake method treating medications, supplements, and hormones as one undifferentiated 'bucket' of exogenous molecules a patient is putting into their body, rather than assessing supplements separately from drugs. Apply: When auditing your own regimen, list every medication, supplement, and hormone together in one inventory instead of treating supplements as automatically low-stakes.
Kidney Filtration Mental Model — A mental model for reviewing a patient's exogenous-molecule bucket: mentally 'dump everything out' and then ask, item by item, what should actually be added back in. Apply: Zero-base your supplement/medication list periodically — assume nothing on it by default, and only re-add an item after justifying it.
Risk-Reward Categorization — A framework for classifying a supplement's overall case into a bucket such as 'low-risk, modest reward,' based on side-effect profile, robustness of safety data, and effect magnitude — applied explicitly to creatine. Apply: After running a supplement through the six-question framework, place it in a risk-reward category to decide whether continued use is justified.
Physiological Saturation Model (creatine clearance) — A model of how creatine is handled once muscle stores are saturated: excess creatine is metabolized by the liver and cleared by the kidneys. Apply: Use this to explain why creatine dosing has a ceiling (3-5g/day maintenance) and why kidney function matters for people taking it.
Pre-Blood-Test Creatine Washout Protocol — A protocol for patients with imperfect kidney function: discontinue creatine 1-2 weeks before blood tests measuring serum creatinine, and always disclose creatine use to the ordering doctor, since high-dose creatine elevates serum creatinine, a key kidney-function metric. Apply: If you take creatine and have any kidney-function concerns, tell your doctor before a metabolic panel and stop creatine 1-2 weeks ahead of the draw to avoid a falsely elevated creatinine reading.
Pure-Ingredient Sourcing Standard — A sourcing rule for choosing a creatine product: buy creatine monohydrate only, with no fillers, since it is the only form with evidence behind it and is inexpensive. Apply: Check the label and pick a product whose sole ingredient is creatine monohydrate (flavoring aside), rejecting other forms or blends.
Pregnancy Medication Discontinuation Protocol — A default clinical stance for women preparing for or during pregnancy: discontinue any non-essential medication or supplement (a category creatine falls into, given insufficient human safety data) for the roughly nine-month window. Apply: If planning pregnancy or pregnant, default to stopping any supplement or medication that isn't strictly necessary until after the nine-month window.
Creatine Dosing Protocol (loading vs. maintenance) — The two historical creatine dosing regimens: an initial loading protocol of about 20g/day, versus a maintenance/saturation dose of 3-5g/day at which effectiveness plateaus. Apply: Use 3-5g/day as an ongoing maintenance dose, since loading isn't required to eventually reach saturation and higher doses don't outperform it once muscle stores are saturated.
The video's cold open directly rebuts the lay assumption that 'natural supplements' are categorically different from 'medicine,' using that rebuttal to justify applying one unified framework to both.
The claim that supplement-space misbehavior outpaces pharma by 10-100x inverts the common assumption that heavier pharma regulation implies pharma is the riskier category.
Because no biomarker exists for creatine tissue saturation, the entire dosing recommendation (3-5g/day) is necessarily protocol-based rather than personalized — a structural gap that the six-question framework itself flags via its own biomarker question.
The female-specific creatine benefit is explained not by a different dosing need (same absolute dose is still recommended) but by pharmacokinetics: smaller body size and lower baseline stores mean the same dose produces a larger relative effect.
High-dose creatine can create a false signal of kidney dysfunction on standard blood work by elevating serum creatinine, making patient disclosure to a physician a practical necessity rather than a formality.
Despite a title promising scrutiny of creatine, fish oil, vitamin D, and more, the free/sneak-peek portion only fully works through creatine — fish oil, vitamin D, B vitamins, and ashwagandha are teased in the cold open and then deferred, with the video pivoting to a premium-subscription pitch before covering them.
«I don't believe in taking any medicine just so you know um only natural supplements my response to that is tell me the difference I mean there is a difference but I just want to make sure you as the consumer of this understand the difference»
— 00:00
«there reasonable evidence to suggest and again we'll we'll link to lots of it that that creatine does help improve various parameters of muscle performance and it's not that subtle I mean it's typically in the range of 5 10 maybe even 15%»
— 00:24
«I I hope that people can use this framework liberally as they try to kind of adjudicate and interrogate their own supplement list»
— 01:21
«A very high dose of red yeast rice is effectively uh a modest dose of pravastatin»
— 06:14
«we just don't have enough human data to to form a strong point of view so obviously the you know in my mind the wise thing to do is to avoid anything that is not absolutely necessary during»
— 21:02
«I would put this in the low-risk modest reward um category we do have I think really robust safety data here»
— 21:57
«high doses of creatine can impact serum doses of creatinin which we would um we would use as one of the metrics to to determine kidney function»
— 22:36
«you should be looking for the purest uh product only that has nothing in it the only ingredient should be creatine monohydrate no fillers»
— 23:25
Reception
Creatine content resonates well with genuine success stories, but frustration with the paywall, clickbait title, and perceived greed tempers overall reception.
The video delivers a genuinely reusable evaluation framework and a thorough, well-sourced creatine case study, but functions structurally as a promotional sneak peek — it teases four other supplements in its cold open, covers only one in full, and closes on a paid-subscription pitch rather than fulfilling the title's broader scope.
27:25